Marshall Wace
LFMD icon

Marshall Wace’s LifeMD LFMD Stock Holding History

Marshall Wace’s Portfolio LFMD Stock Details LFMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.3M Buy
557,474
+300,339
+117% +$1.33M ﹤0.01% 1782
2026
Q1 		$928K Buy
+257,135
New +$890K ﹤0.01% 2173
2025
Q2 		– Sell
-315,865
Closed -$1.72M – 2954
2025
Q1 		$1.72M Sell
315,865
-55,608
-15% -$315K ﹤0.01% 1535
2024
Q4 		$1.84M Buy
371,473
+311,841
+523% +$1.63M ﹤0.01% 1473
2024
Q3 		$312K Sell
59,632
-225,134
-79% -$1.3M ﹤0.01% 2120
2024
Q2 		$1.95M Sell
284,766
-352
-0.1% -$3.22K ﹤0.01% 1386
2024
Q1 		$2.93M Sell
285,118
-36,773
-11% -$272K ﹤0.01% 1205
2023
Q4 		$2.67M Sell
321,891
-106,695
-25% -$767K ﹤0.01% 1109
2023
Q3 		$2.68M Buy
428,586
+298,665
+230% +$1.29M 0.01% 1093
2023
Q2 		$565K Buy
+129,921
New +$288K ﹤0.01% 1945
2022
Q1 		– Sell
-128,119
Closed -$496K – 3704
2021
Q4 		$496K Buy
128,119
+116,786
+1,030% +$552K ﹤0.01% 2801
2021
Q3 		$70K Buy
+11,333
New +$96.7K ﹤0.01% 2918

Other funds holding LFMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PGCM
Prescott Group Capital Management Tulsa, Oklahoma $1.16B AUM 53.61% 1-Year Est. Return
BRF
B. Riley Financial Los Angeles, California $434M AUM 751.56% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Marshall Wace's LFMD Position: Q2 2026 in Review

Marshall Wace increased its LifeMD (LFMD) stake by 117% in Q2 2026, buying an estimated $1.33M and bringing the position to 557,474 shares worth $2.3M. The position accounts for ﹤0.01% of the portfolio, ranked #1782.

Marshall Wace first reported a position in LFMD in Q3 2021 and has held it in 12 quarters since. The position peaked at $2.93M in Q1 2024. 116 funds tracked by Wall St. Rank hold LFMD as of Q2 2026.

  • Marshall Wace held 557,474 shares of LifeMD worth $2.3M as of Q2 2026.
  • Marshall Wace bought 300,339 LifeMD shares in Q2 2026, an estimated $1.33M.
  • LifeMD made up ﹤0.01% of Marshall Wace's portfolio in Q2 2026, its #1782 holding.
  • Marshall Wace first reported a position in LifeMD in Q3 2021 and has held it in 12 quarters since.
  • Marshall Wace's LifeMD position peaked at $2.93M in Q1 2024.
  • 116 funds tracked by Wall St. Rank held LifeMD as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.